Pharma's Zika Pursuit: All About The Profits?

When the National Institute of Allergy and Infectious Diseases (NIAID) developed an experimental West Nile virus vaccine, it struggled to find an industry partner to take the product through advanced development and to the marketplace, despite a great public health need, said the agency's director, Anthony Fauci.

When the National Institute of Allergy and Infectious Diseases (NIAID) developed an experimental West Nile virus vaccine, it struggled to find an industry partner to take the product through advanced development and to the marketplace, despite a great public health need, said the agency's director, Anthony Fauci.

Not even the successful Phase I trial of the investigational West Nile product, which showed good safety and immunogenicity, was...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category